These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 15611996)
1. Effect of neurokinins on canine prostate cell physiology. Walden PD; Marinese D; Srinivasan D; Tzoumaka E; Syyong HT; Ford AP; Bhattacharya A Prostate; 2005 Jun; 63(4):358-68. PubMed ID: 15611996 [TBL] [Abstract][Full Text] [Related]
2. Neurokinin receptor modulation of respiratory activity in the rabbit. Bongianni F; Mutolo D; Cinelli E; Pantaleo T Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294 [TBL] [Abstract][Full Text] [Related]
3. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study. Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127 [TBL] [Abstract][Full Text] [Related]
4. Androgen and prostatic stroma. Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms mediating substance P-induced contraction in the rat iris in vitro. Grumann-JĂșnior A; Dias MA; Alves RV; Boteon JE; Calixto JB Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1861-70. PubMed ID: 10845610 [TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptor-2 activation evokes oesophageal longitudinal smooth muscle contraction via a capsaicin-sensitive and neurokinin-2 receptor-dependent pathway. Liu H; Miller DV; Lourenssen S; Wells RW; Blennerhassett MG; Paterson WG Neurogastroenterol Motil; 2010 Feb; 22(2):210-6, e67. PubMed ID: 19740117 [TBL] [Abstract][Full Text] [Related]
7. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1. Nakamura M; Ofuji K; Chikama T; Nishida T Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288 [TBL] [Abstract][Full Text] [Related]
8. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries. Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors. Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556 [TBL] [Abstract][Full Text] [Related]
10. Tachykinin receptor expression and function in human esophageal smooth muscle. Kovac JR; Chrones T; Preiksaitis HG; Sims SM J Pharmacol Exp Ther; 2006 Aug; 318(2):513-20. PubMed ID: 16714401 [TBL] [Abstract][Full Text] [Related]
11. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips. Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807 [TBL] [Abstract][Full Text] [Related]
12. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues, and in bone and dental hard tissue cells. Fristad I; Vandevska-Radunovic V; Fjeld K; Wimalawansa SJ; Hals Kvinnsland I Cell Tissue Res; 2003 Mar; 311(3):383-91. PubMed ID: 12658446 [TBL] [Abstract][Full Text] [Related]
13. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human. Lecci A; Capriati A; Altamura M; Maggi CA Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the human neurokinin receptors NK1, NK2, and NK3 based on a cellular assay system. Stratowa C; Machat H; Burger E; Himmler A; Schafer R; Spevak W; Weyer U; Wiche-Castanon M; Czernilofsky AP J Recept Signal Transduct Res; 1995; 15(1-4):617-30. PubMed ID: 8903968 [TBL] [Abstract][Full Text] [Related]
15. Tachykinin activation of human monocytes from patients with rheumatoid arthritis: in vitro and ex-vivo effects of cyclosporin A. Lavagno L; Bordin G; Colangelo D; Viano I; Brunelleschi S Neuropeptides; 2001 Apr; 35(2):92-9. PubMed ID: 11384204 [TBL] [Abstract][Full Text] [Related]
16. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347 [TBL] [Abstract][Full Text] [Related]
17. Substance P, neurokinins A and B, and synthetic tachykinin peptides protect mesencephalic dopaminergic neurons in culture via an activity-dependent mechanism. Salthun-Lassalle B; Traver S; Hirsch EC; Michel PP Mol Pharmacol; 2005 Nov; 68(5):1214-24. PubMed ID: 16077032 [TBL] [Abstract][Full Text] [Related]
18. Neurokinin A-induced vasoconstriction and muscular contraction in the rat isolated stomach: mediation by distinct and unusual neurokinin2 receptors. Lippe I; Wachter CH; Holzer P J Pharmacol Exp Ther; 1997 Jun; 281(3):1294-302. PubMed ID: 9190865 [TBL] [Abstract][Full Text] [Related]
19. Characterization of [3H]substance P binding sites in human skin. Bianchi B; Matucci R; Danesi A; Rossi R; Ipponi P; Giannotti B; Johansson O; Cappugi P J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):6-10. PubMed ID: 10188142 [TBL] [Abstract][Full Text] [Related]
20. Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle. Sellers DJ; Chapple CR; W Hay DP; Chess-Williams R Eur Urol; 2006 Mar; 49(3):510-8. PubMed ID: 16420969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]